After the North American Free Trade Agreement (NAFTA) was signed on 1994, an assessment determined the strategic importance of Mexico and therefore the convenience of concentrating part of the manufacture of human health products for this large market in our production facility, which is certified by the Food and Drug Administration (FDA) .

Our industrial complex, with an investment of USD$ 70 million, has a production capacity of 140 million units per year. This complex includes a modern facility for the production of solid forms (tablets, capsules and coated tablets), a refurbished facility for the production of liquid forms (syrups and solutions), a quality assurance laboratory and a totally automated warehouse. The design of both facilities, as well as the totally automated warehouse, was created by Mexican architects jointly with German experts and international high-technology suppliers. It is completely avant-garde and gathers important elements of functionality, productivity, energy saving, security, environmental care and hygiene.